EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CXCL14 Chemokine Exacerbates Acute Viral Hepatitis in Coronavirus MHV ‐Infected Mice and Is Associated With Human Acute Viral Hepatitis

Christelle Devisme, Claire Piquet-Pellorce, Arnaud Chalin, Benjamin Lefevre, Charlotte Pronier, Vincent Thibault, Jacques Le Seyec, Céline Raguénès-Nicol, Charaf Benarafa, Michel Samson

The FASEB Journal · 2025

DOI: 10.1096/fj.202401706r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Christelle Devisme und 9 weiteren Autor:innen. Beteiligte Einrichtung: University of Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, Rennes, France. Hauptthemen laut MEDLINE: Murine hepatitis virus, Chemokines, CXC, Hepatitis, Viral, Human, Coronavirus Infections. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Institut National de la Santé et de la Recherche Médicale (Inserm), Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation (MESRI), Université de Rennes 1 (University of Rennes 1).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deaths from viral hepatitis continue to rise around the world due to the lack of early biomarkers. We aimed here to evaluate the chemokine CXCL14, as a novel biomarker in acute viral hepatitis. We used a mouse model of acute hepatitis induced by murine hepatitis virus (MHV), a hepatotropic and lytic coronavirus, and showed that CXCL14 is overexpressed in the liver and sera of infected mice. Using primary cultures of murine and human hepatocytes, we showed that hepatocytes are the main source of CXCL14 after lytic hepatotropic virus infection and that CXCL14 expression is also induced by the pro‐inflammatory cytokines IL‐6 and TNFα. CXCL14 KO mice infected with MHV were partially protected and showed an attenuated antiviral immune response compared to wild‐type mice. Finally, we show that CXCL14 is overexpressed in the sera of human patients infected with hepatitis viruses A, B, and E or herpes simplex virus. A positive correlation between CXCL14 and ALT levels in the sera of patients with acute herpetic hepatitis, as well as in mice models, suggests that hepatocyte lysis is necessary for the release of CXCL14. Overall, these data highlight that CXCL14 expression is associated with the occurrence of acute viral hepatitis and could be considered an alarmin and a new indicator of inflammation. CXCL14 serum levels are also associated with the severity of viral‐induced liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Murine hepatitis virusChemokines, CXCHepatitis, Viral, HumanCoronavirus InfectionsHepatitis, Viral, AnimalAnimalsHumansMiceMice, KnockoutHepatocytesMice, Inbred C57BLMaleFemaleLiverDisease Models, Animal

Stichwörter der Autor:innen

CXCL14acute viral hepatitisalarminchemokinehuman blood sampleimmune responsemouse animal

Substanzen

Chemokines, CXCCXCL14 protein, mouseCXCL14 protein, human

Autor:innen und Institutionen

  • University of Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, Rennes, France.
  • Institute of Virology and Immunology, Mittelhäusern, Switzerland.
  • Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • University of Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, Rennes, France.
  • Multidisciplinary Center for Infectious Diseases, University of Bern, Bern, Switzerland.

Förderung

  • Institut National de la Santé et de la Recherche Médicale (Inserm)
  • Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation (MESRI)
  • Université de Rennes 1 (University of Rennes 1)
  • Région Bretagne (Region Bretanii)
  • Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS)
  • Fondation pour la Recherche Médicale (FRM)

Zitieren

APA

Devisme, C., Piquet-Pellorce, C., Chalin, A., Lefevre, B., Pronier, C., Thibault, V., Le Seyec, J., Raguénès-Nicol, C., Benarafa, C., & Samson, M. (2025). CXCL14 Chemokine Exacerbates Acute Viral Hepatitis in Coronavirus MHV ‐Infected Mice and Is Associated With Human Acute Viral Hepatitis. The FASEB Journal. https://doi.org/10.1096/fj.202401706r

Vancouver

Devisme C, Piquet-Pellorce C, Chalin A, Lefevre B, Pronier C, Thibault V, et al. CXCL14 Chemokine Exacerbates Acute Viral Hepatitis in Coronavirus MHV ‐Infected Mice and Is Associated With Human Acute Viral Hepatitis. The FASEB Journal. 2025. doi:10.1096/fj.202401706r

BibTeX
@article{Devisme2025,
  author = {Devisme, Christelle and Piquet-Pellorce, Claire and Chalin, Arnaud and Lefevre, Benjamin and Pronier, Charlotte and Thibault, Vincent and Le Seyec, Jacques and Raguénès-Nicol, Céline and Benarafa, Charaf and Samson, Michel},
  title = {CXCL14 Chemokine Exacerbates Acute Viral Hepatitis in Coronavirus MHV ‐Infected Mice and Is Associated With Human Acute Viral Hepatitis},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202401706r}
}
Kostenlos starten →